Whole-Body MR Imaging: Evaluation of Patients for Metastases

Thomas C. Lauenstein, Susanne C. Goehde, Christoph U. Herborn, +5

Radiology

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study

C. Oberhoff, B Neri, D. Amadori, +11

Annals of Oncology

MedicineAplastic AnemiaTransfusion MedicineHematologyBlood Transfusion +7

Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.

M. E. Scheulen, Ralf A. Hilger, C. Oberhoff, +12

PubMed

Cell TherapyPathologyPharmacotherapyMetronomic ChemotherapyImmunotherapy +16

Topotecan Chemotherapy in Patients with Breast Cancer and Brain Metastases: Results of a Pilot Study

C. Oberhoff, D. G. Kieback, Rachel Würstlein, +8

Oncology Research and Treatment

Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.

Holger Thurm, Sebastian Ebel, Christina Kentenich, +8

PubMed

Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer

Anja Welt, Gϋnter von Minckwitz, C. Oberhoff, +7

Annals of Oncology

Pretreated PatientsMetastatic Breast CancerBreast OncologyPhase I/ii StudyMedicine +7

Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors

Ralf A. Hilger, A. Harstrick, Wilfried Eberhardt, +5

Cancer Chemotherapy and Pharmacology

Intravenous TreosulfanTherapeutic Drug MonitoringOncologyMedicineAdvanced Solid Tumors +6

Is first-line single-agent mitoxantrone in the treatment ofhigh-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial

E. Heidemann, Herbert Stoeger, Rainer Souchon, +12

Annals of Oncology

Breast OncologyOncologyCombination ChemotherapyHigher QualityMedicine +7

A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study

Jalid Sehouli, Ingo B. Runnebaum, Christina Fotopoulou, +17

Annals of Oncology

Cervical Cancer ManagementRadiation MedicineCervical CancerRadiation TherapyMedicine +9

Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial

O. Kloke, U. Klaassen, C. Oberhoff, +17

Breast Cancer Research and Treatment

Medroxyprogesterone AcetateBreast OncologyOncologyMaintenance TreatmentMedicine +6